Skip to main content

Together we are beating cancer

Donate now

Tests

Showing 12 out of 224 results
Microscopic images of pleural fluid cytology of a small cell oat cell carcinoma
  • Science & Technology
  • Health & Medicine

12 ways we’ve influenced progress in lung cancer 

From uncovering some of the causes of lung cancer, through to contributing to drugs used to treat it, here are 12 ways we have worked towards progress in lung cancer. From uncovering some of the causes of lung cancer, through to contributing to drugs used to treat it, here are 12 ways we have worked towards progress in lung cancer.

by Amy Warnock | 31 October 2024

31 October 2024

3D image of blood vessels in the hand, taken using a photoacoustic tomography scanner.

A new scanner, that has been developed by University College London (UCL) researchers, is able to generate highly detailed 3D images in seconds. Using this technology could offer the potential for earlier disease diagnosis in a clinical setting for the first time. A new scanner, that has been developed by University College London (UCL) researchers, is able to generate highly detailed 3D images in seconds. Using this technology could offer the potential for earlier disease diagnosis in a clinical setting for the first time.

by Sophie Wedekind | News | 15 October 2024

15 October 2024

Microscopic image of core biopsy for infiltrating (invasive) ductal carcinoma, detected by screening mammogram

Our researchers have published a paper showing that their alternative BRCA testing pathway, BRCA-DIRECT, could be a more convenient way to test for faulty BRCA genes in people with breast cancer Our researchers have published a paper showing that their alternative BRCA testing pathway, BRCA-DIRECT, could be a more convenient way to test for faulty BRCA genes in people with breast cancer

by Fiona Scott | News | 1 October 2024

1 October 2024

This entry is part 2 of 4 in the series Multi-cancer tests
Sânziana Foia in the lab with an image of Papcup, the new HPV test she has designed for cervical screening, on a laptop.

Sânziana Foia is developing a cervical screening device designed to detect high-risk HPV in menstrual blood within minutes. It could help remove some of the biggest barriers to cervical screening, helping many more eligible people take part.  Sânziana Foia is developing a cervical screening device designed to detect high-risk HPV in menstrual blood within minutes. It could help remove some of the biggest barriers to cervical screening, helping many more eligible people take part. 

by Sadaf Shafaghmotlagh | Analysis | 4 September 2024

4 September 2024

A woman reading a cancer information limit while waiting to see the doctor.

Testing women with symptoms that could be linked to ovarian cancer is an effective way of finding aggressive forms of the disease in their early stages, according to research we helped fund. Testing women with symptoms that could be linked to ovarian cancer is an effective way of finding aggressive forms of the disease in their early stages, according to research we helped fund.

by Tim Gunn | News | 15 August 2024

15 August 2024

Squamous epithelial cells of human cervix under the microscope view.
  • Science & Technology
  • Health & Medicine

70 years of progress in cervical cancer research

25 years ago, our scientists showed that nearly all cervical cancers are caused by the human papillomavirus (HPV). But that’s not where our story with cervical cancer research starts, and it certainly isn’t where it ends. 25 years ago, our scientists showed that nearly all cervical cancers are caused by the human papillomavirus (HPV). But that’s not where our story with cervical cancer research starts, and it certainly isn’t where it ends.

by Jacob Smith | In depth | 17 June 2024

17 June 2024

Visitors at the National Biomarker Centre

Today marks the opening of the Cancer Research UK National Biomarker Centre, a new state-of-the-art facility in Manchester which will help experts detect cancer at an earlier stage – when there are usually more treatment options available. Today marks the opening of the Cancer Research UK National Biomarker Centre, a new state-of-the-art facility in Manchester which will help experts detect cancer at an earlier stage – when there are usually more treatment options available.

by Amy Warnock | News | 14 June 2024

14 June 2024

A computer-generated image showing a DNA double-helix in a blood sample

Multi-cancer tests have the potential to detect multiple cancer types from a single sample. There's a lot to learn before we can use them. Multi-cancer tests have the potential to detect multiple cancer types from a single sample. There's a lot to learn before we can use them.

by Jessica Lloyd, Alice Brookes | In depth | 12 June 2024

12 June 2024

This entry is part 1 of 4 in the series Multi-cancer tests
Sample bottles in a lab

A spit test that predicts people's genetic risk of prostate cancer could help find more cases earlier, according to the BARCODE 1 trial. A spit test that predicts people's genetic risk of prostate cancer could help find more cases earlier, according to the BARCODE 1 trial.

by Tim Gunn | News | 1 June 2024

1 June 2024

A medical professional holding a tube containing a blood sample

Researchers in Manchester have developed CUPiD, a blood test that could transform the diagnostic journey of someone with cancer of unknown primary. Researchers in Manchester have developed CUPiD, a blood test that could transform the diagnostic journey of someone with cancer of unknown primary.

by Jacob Smith | In depth | 23 April 2024

23 April 2024